fashion -WSS

fashion

author：fashion 2025-08-28 13:03:50 - browse：3

Adam's take main illustration — Molly Ferguson/STAT

The Food and Drug Administration should halt Cassava Sciences’ ongoing clinical trials in Alzheimer’s disease. That, and other thoughts on the fallout from the City University of New York investigation that raised serious doubts about the science underpinning the company’s experimental drug simufilam.

Patient safety is paramount to the FDA, so stopping Cassava’s two Phase 3 studies is the ethically correct thing to do.The FDA has the power to place clinical holds on experimental drugs when there’s evidence of an unacceptable safety risk to study participants. Simufilam doesn’t appear to be toxic. It’s not causing dangerous side effects. But study participants can also be harmed when they volunteer for a clinical trial based on false or misleading information about a drug’s potential efficacy.

The CUNY committee charged with investigating Cassava’s principal scientific collaborator, the neuroscientist Hoau-Yan Wang, could not definitively prove that Wang faked simufilam data, but that’s only because he refused to turn over original data and primary research records that the committee had requested to examine. Wang also claimed that boxes of research records relevant to the investigation were thrown away. The investigative report was first made public last week in the journal Science.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Blood tests recalled over risk of missed heart attack diagnosis

hotspot

WSS

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

hotspot

fashion

leisure time

Apple is now the first public company to be valued at $3 trillion

RSV vaccines may be linked to small increased risk of developing GBS

New air purifier tech could be key to improving indoor air quality

Biotech companies concerned about China biosecurity crackdown

In Memoriam: Notable people who died in 2023

Federal judge rules Oregon’s tough new gun law is constitutional

The high cost of giving birth even with insurance

Change Healthcare cyberattack outage could last weeks

State Dept. review finds Biden bears some blame for Afghanistan failures

ALS groups 'won't be played again' by the FDA, drug sponsors

entertainment

Grail faces three suits alleging harassment, retaliation

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Woman gored by Bison at Yellowstone

Pfizer highlights cancer drugs it thinks could reignite investor interest

Federal judge rules Oregon’s tough new gun law is constitutional

Europe sees delivery challenges ahead on Alzheimer's therapies

knowledge

hotspot

leisure time

explore